The DOI matches its Crossref record; 190 of the 190 references it cites were found in a registry or an index.
Recent developments in age-related macular degeneration: a review
Open accessAbstract
BACKGROUND: Visual impairment in elderly people is a considerable health problem that significantly affects quality of life of millions worldwide. The magnitude of this issue is becoming more evident with an aging population and an increasing number of older individuals. OBJECTIVE: The objective of this article was to review the clinical and pathological aspects of age-related macular degeneration (AMD), diagnostic tools, and therapeutic modalities presently available or underway for both atrophic and wet forms of the disease. METHODS: An online review of the PubMed database was performed, searching for the key words. The search was limited to articles published since 1980 to date. RESULTS: Several risk factors have been linked to AMD, such as age (>60 years), lifestyle (smoking and diet), and family history. Although the pathogenesis of AMD remains unclear, genetic factors have been implicated in the condition. Treatment for atrophic AMD is mainly close observation, coupled with nutritional supplements such as zinc and antioxidants, whereas treatment of wet AMD is based on targeting choroidal neovascular membranes. CONCLUSION: Identification of modifiable risk factors would improve the possibilities of preventing the progression of AMD. The role of anti-vascular endothelial growth factor (anti-VEGF) agents has transformed the therapeutic approach of the potentially blinding disease "wet AMD" into a more favorable outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Potential role of lampalizumab for treatment of geographic atrophy
Diana, V., Rhoades, W. R., & Dickson, D. (2015) · Clinical ophthalmology · doi:10.2147/opth.s59725 · Cited by 26
RetractedRanibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
De Cillà, S. D., Farruggio, S., Vujosevic, S., Raina, G., Filippini, D., Gatti, V., Clemente, N., Mary, D., Vezzola, D., Casini, G., et al. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479441 · Cited by 5,136
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 1×
“CFH suppresses complement pathway; hence, in the presence of abnormal CFH activity, the complement cascade is activated with a consequent downstream inflammatory response to subretinal tissues.(14) Inflammatory components from the cascade pathway have been identified within drusen,(10) and additionally, environmental…”
Bird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
Fritsche, L. G., Igl, W., Bailey, J. N. C., Grassmann, F., Sengupta, S., Bragg-Gresham, J. L., Burdon, K. P., Hebbring, S. J., Wen, C., Gorski, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3448 · Cited by 1,544
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61376-3 · Cited by 1,327 · cited 1×
“110 Although the procedure was well tolerated and patients were followed for up to 3 years, these findings only support proof of concept and are too preliminary to suggest its use in treatment.”
Brown, D. M., Michels, M., Kaiser, P. K., Heier, J. S., Sy, J. P., & Ianchulev, T. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.10.018 · Cited by 1,318
Imaging of Macular Diseases with Optical Coherence Tomography
Puliafito, C. A., Hee, M. R., Lin, C. P., Reichel, E., Schuman, J. S., Duker, J. S., Izatt, J. A., Swanson, E. A., & Fujimoto, J. G. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31032-9 · Cited by 1,267
Leibowitz, H. M., Krueger, D. E., Maunder, L. R., Milton, R. C., KINI, M. M., Kahn, H. A., Nickerson, R. J., Pool, J., Colton, T., Ganley, J. P., et al. (1980) · PubMed · Cited by 1,250
The Wisconsin Age-related Maculopathy Grading System
Klein, R., Davis, M. D., Magli, Y. L., Segal, P., Klein, B. E. K., & Hubbard, L. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32186-9 · Cited by 1,200
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · cited 3×
“In contrast, another study found protective effects of genetic polymorphisms in complement factor B (CFB), complement component 2 (C2) on chromosome 6, and specific haplotypes in CFH that demonstrated decreased risk of AMD.(11) CFH suppresses complement pathway; hence, in the presence of abnormal CFH activity, the com…”
InfluentialRisk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071
Papadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
Fung, A. E., Lalwani, G. A., Rosenfeld, P. J., Dubovy, S. R., Michels, S., Feuer, W. J., Puliafito, C. A., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.028 · Cited by 972
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies
Ambati, J., Ambati, B. K., Yoo, S. H., Ianchulev, S., & Adamis, A. P. (2003) · Survey of Ophthalmology · doi:10.1016/s0039-6257(03)00030-4 · Cited by 959 · cited 1×
“Low levels of the ribonucleic acid (RNA)-cleaving enzyme, DICER1, in RPE cells were observed in patients with dry AMD.(21) It was reported that decreased levels of DICER1 lead to a decreased rate in the breakdown of RNA-Alu molecules, which are noncoding sequences of RNA.”
Lalwani, G. A., Rosenfeld, P. J., Fung, A. E., Dubovy, S. R., Michels, S., Feuer, W., Davis, J. L., Flynn, H. W., & Esquiabro, M. (2009) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2009.01.024 · Cited by 880
Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis
Chakravarthy, U., Wong, T. Y., Fletcher, A., Piault, E., Evans, C., Zlateva, G., Buggage, R., Pleil, A., & Mitchell, P. (2010) · BMC Ophthalmology · doi:10.1186/1471-2415-10-31 · Cited by 842 · cited 2×
“25 Although infrequent in people younger than 50 years, the risk of acquiring AMD increases more than threefold in patients older than 75 years compared to patients between 65 and 74 years of age.”
A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No. 18
(2005) · Archives of Ophthalmology · doi:10.1001/archopht.123.11.1570 · Cited by 807
Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Wordsworth, S., & Reeves, B. C. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.04.015 · Cited by 781
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Culliford, L. A., & Reeves, B. C. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61501-9 · Cited by 748 · cited 1×
“134 A meta-analysis evaluating the results of the data from both the CATT and the IVAN trials convincingly demonstrated that bevacizumab was not inferior to ranibizumab in best-corrected VA in patients with wet AMD.”
Jia, Y., Bailey, S. T., Wilson, D. J., Tan, O., Klein, M. L., Flaxel, C. J., Potsaid, B., Liu, J. J., Lu, C. D., Kraus, M. F., et al. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.01.034 · Cited by 729
Weber, B. H. F., Vogt, G., Pruett, R. C., Stöhr, H., & Felbor, U. (1994) · Nature Genetics · doi:10.1038/ng1294-352 · Cited by 656
Risk factors associated with age-related macular degeneration
(2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00409-7 · Cited by 633
Johnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621
INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
SPAIDE, R. F., YANNUZZI, L. A., SLAKTER, J. S., SORENSON, J., & ORLACH, D. A. (1995) · Retina · doi:10.1097/00006982-199515020-00003 · Cited by 608
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Kaneko, H., Dridi, S., Tarallo, V., Gelfand, B. D., Fowler, B. J., Cho, W. G., Kleinman, M. E., Ponicsan, S. L., Hauswirth, W. W., Chiodo, V. A., et al. (2011) · Nature · doi:10.1038/nature09830 · Cited by 601
Maller, J., George, S., Purcell, S., Fagerness, J., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · Nature Genetics · doi:10.1038/ng1873 · Cited by 599
Bressler, N. M. (2001) · Cited by 599
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
Tarallo, V., Hirano, Y., Gelfand, B. D., Dridi, S., Kerur, N., Kim, Y., Cho, W. G., Kaneko, H., Fowler, B. J., Bogdanovich, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.036 · Cited by 592
Ho, A. C., Busbee, B. G., Regillo, C. D., Wieland, M. R., Van Everen, S. A., Li, Z., Rubio, R. G., & Lai, P. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.05.009 · Cited by 590
Age-related macular degeneration
Coleman, H. R., Chan, C.-C., Ferris, F. L., & Chew, E. Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61759-6 · Cited by 542
Distribution of fundus autofluorescence with a scanning laser ophthalmoscope.
von Ruckmann, A., Fitzke, F. W., & Bird, A. C. (1995) · British Journal of Ophthalmology · doi:10.1136/bjo.79.5.407 · Cited by 525
Busbee, B. G., Ho, A. C., Brown, D. M., Heier, J. S., Suñer, I. J., Li, Z., Rubio, R. G., & Lai, P. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.10.014 · Cited by 500
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
Susceptibility genes for age-related maculopathy on chromosome 10q26
Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Mah, T. S., Ferrell, R. E., & Gorin, M. B. (2005) · The American Journal of Human Genetics · doi:10.1086/444437 · Cited by 470
Hughes, A. E., Orr, N., Esfandiary, H., Diaz-Torres, M., Goodship, T., & Chakravarthy, U. (2006) · Nature Genetics · doi:10.1038/ng1890 · Cited by 467
Neale, B. M., Fagerness, J., Reynolds, R., Sobrin, L., Parker, M., Raychaudhuri, S., Tan, P. L., Oh, E. C., Merriam, J. E., Souied, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912019107 · Cited by 442 · cited 1×
“…related to AMD include a polymorphism in lipase C hepatic type ( LIPC ), which is involved in high-density lipoprotein cholesterol metabolism; 34 the single-nucleotide polymorphism (SNP) rs3775291 in toll-like receptor 3 ( TLR3 ); 19 and the tissue inhibitor of metalloproteinase 3 ( TIMP3 ).”
Argon Laser Photocoagulation for Senile Macular Degeneration: Results of a Randomized Clinical Trial
(1982) · Archives of Ophthalmology · doi:10.1001/archopht.1982.01030030920003 · Cited by 405
Christen, W. G., Gaziano, J. M., & Hennekens, C. H. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00042-3 · Cited by 376
Singer, M. A., Awh, C. C., Sadda, S., Freeman, W. R., Antoszyk, A. N., Wong, P., & Tuomi, L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.016 · Cited by 356
Oral Zinc in Macular Degeneration
Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C., & Miller, E. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130202026 · Cited by 349 · cited 1×
“97 The AREDS study was designed to determine whether anti-oxidant supplementation could have protective effects against AMD.”
Zweifel, S. A., Imamura, Y., Spaide, T. C., Fujiwara, T., & Spaide, R. F. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.01.027 · Cited by 331
Pathologic Features of Senile Macular Degeneration
GREEN, W. R., McDONNELL, P. J., & YEO, J. H. (2005) · Retina · doi:10.1097/00006982-200507001-00011 · Cited by 313
Optical Coherence Tomography: History, Current Status, and Laboratory Work
Gabriele, M. L., Wollstein, G., Ishikawa, H., Kagemann, L., Xu, J., Folio, L. S., & Schuman, J. S. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6312 · Cited by 310
(1993) · Archives of Ophthalmology · doi:10.1001/archopht.1993.01090090052019 · Cited by 303
The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date
Haddad, S., Chen, C. A., Santangelo, S. L., & Seddon, J. M. (2006) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2006.05.001 · Cited by 299 · cited 1×
“Twin studies have demonstrated that family history is an established risk factor for AMD.(9) One study recently reported that drusen formation may stimulate an inflammatory cascade that has a role in AMD progression.”
Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration
Biesemeier, A., Taubitz, T., Julien, S., Yoeruek, E., & Schraermeyer, U. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.003 · Cited by 287
(2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.07.023 · Cited by 279
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope
Struharova, K., & Cernak, M. (2012) · Bratislava Medical Journal · doi:10.4149/bll_2012_026 · Cited by 273
A Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration
Gupta, O. P., Shienbaum, G., Patel, A. H., Fecarotta, C., Kaiser, R. S., & Regillo, C. D. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2010.02.032 · Cited by 272
The Long-term Natural History of Geographic Atrophy from Age-Related Macular Degeneration
Sunness, J. S., Margalit, E., Srikumaran, D., Applegate, C. A., Tian, Y., Perry, D., Hawkins, B. S., & Bressler, N. M. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.09.016 · Cited by 265
Wu, Z., Luu, C. D., Ayton, L. N., Goh, J. K., Lucci, L. M., Hubbard, W. C., Hageman, J. L., Hageman, G. S., & Guymer, R. H. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2014.06.034 · Cited by 264
The Prevalence of Blindness and Visual Impairment among Nursing Home Residents in Baltimore
Tielsch, J. M., Javitt, J. C., Coleman, A., Katz, J., & Sommer, A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321806 · Cited by 260
Kodjikian, L., Souied, E. H., Mimoun, G., Mauget-Faÿsse, M., Behar-Cohen, F., Decullier, E., Huot, L., & Aulagner, G. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.06.020 · Cited by 257
Do blue light filters confer protection against age-related macular degeneration?
MARGRAIN, T. (2004) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.05.001 · Cited by 257
Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration
Midena, E., Vujosevic, S., Convento, E., Manfre', A., Cavarzeran, F., & Pilotto, E. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.119685 · Cited by 255
Age-related Macular Degeneration: Clinical Features in a Large Family and Linkage to Chromosome 1q
Klein, M. L. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.8.1082 · Cited by 252
Chew, E. Y., Clemons, T. E., Agrón, E., Sperduto, R. D., SanGiovanni, J. P., Davis, M. D., & Ferris, F. L. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.6636 · Cited by 237
The Epidemiology of Retinal Reticular Drusen
Klein, R., Meuer, S. M., Knudtson, M. D., Iyengar, S. K., & Klein, B. E. K. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.09.008 · Cited by 231
Cataract surgery and the 5-year incidence of late-stage age-related maculopathy
Wang, J. J., Klein, R., Smith, W., Klein, B. E. K., Tomany, S., & Mitchell, P. (2003) · Ophthalmology · doi:10.1016/s0161-6420(03)00816-9 · Cited by 229
Chong, E. W.-T., Wong, T. Y., Kreis, A. J., Simpson, J. A., & Guymer, R. H. (2007) · BMJ · doi:10.1136/bmj.39350.500428.47 · Cited by 225
BRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (2005) · Retina · doi:10.1097/00006982-200507001-00016 · Cited by 224
Johnson, P. T., Betts, K. E., Radeke, M. J., Hageman, G. S., Anderson, D. H., & Johnson, L. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606234103 · Cited by 223
Toll-like Receptor 3 and Geographic Atrophy in Age-Related Macular Degeneration
Yang, Z., Stratton, C., Francis, P. J., Kleinman, M. E., Tan, P. L., Gibbs, D., Tong, Z., Chen, H., Constantine, R., Yang, X., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802437 · Cited by 222
The relationships of age changes in retinal pigment epithelium and Bruch's membrane.
Okubo, A., Rosa, R. H., Bunce, C., Alexander, R., Fan, J. T., Bird, A. C., & Luthert, P. J. (1999) · PubMed · Cited by 206
Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.
von Rückmann, A., Fitzke, F. W., & Bird, A. C. (1997) · PubMed · Cited by 204
Age-related macular degeneration–a genome scan in extended families
Majewski, J., Schultz, D. W., Weleber, R. G., Schain, M. B., Edwards, A. O., Matise, T. C., Acott, T. S., Ott, J., & Klein, M. L. (2003) · The American Journal of Human Genetics · doi:10.1086/377701 · Cited by 201
Geerlings, M. J., de Jong, E. K., & den Hollander, A. I. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2016.11.016 · Cited by 201
BRESSLER, N. M., SILVA, J. C., BRESSLER, S. B., FINE, S. L., & GREEN, W. R. (1994) · Retina · doi:10.1097/00006982-199414020-00006 · Cited by 200 · cited 1×
“Drusen formation signals RPE dysfunction, which promotes RPE loss with further progression that results in photoreceptor death.(18) As previously described, RPE degeneration consequently leads to dysfunction of Bruch’s membrane.”
BackgroundChew, E. Y., Clemons, T. E., Bressler, S. B., Elman, M. J., Danis, R. P., Domalpally, A., Heier, J. S., Kim, J. E., & Garfinkel, R. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.10.027 · Cited by 191
Antoszyk, A. N., Tuomi, L., Chung, C. Y., & Singh, A. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.12.029 · Cited by 190
Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity
Szeto, H. H., & Birk, A. V. (2014) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2014.174 · Cited by 188
Nordgaard, C. L., Karunadharma, P. P., Feng, X., Olsen, T. W., & Ferrington, D. A. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1352 · Cited by 188
Sepp, T., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Moore, A. T., Bird, A. C., & Yates, J. R. W. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1143 · Cited by 186
Bindewald, A. (2005) · British Journal of Ophthalmology · doi:10.1136/bjo.2004.057794 · Cited by 186
Schmitz-Valckenberg, S., Bindewald-Wittich, A., Dolar-Szczasny, J., Dreyhaupt, J., Wolf, S., Scholl, H. P. N., & Holz, F. G. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0892 · Cited by 181
Carotenoids and Antioxidants in Age-Related Maculopathy Italian Study
Parisi, V., Tedeschi, M., GALLINARO, G., Varano, M., Saviano, S., & Piermarocchi, S. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.029 · Cited by 170
Age-Related Macular Degeneration: Advances in Management and Diagnosis
Yonekawa, Y., Miller, J. W., & Kim, I. K. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4020343 · Cited by 169
Genetic and environmental factors influencing the human factor�H plasma levels
Esparza-Gordillo, J., Soria, J. M., Buil, A., Almasy, L., Blangero, J., Fontcuberta, J., & Rodr�guez de C�rdoba, S. (2004) · Immunogenetics · doi:10.1007/s00251-004-0660-7 · Cited by 167
Vitamin E supplementation and macular degeneration: randomised controlled trial
Taylor, H. R., Tikellis, G., Robman, L. D., McCarty, C. A., & McNeil, J. J. (2002) · BMJ · doi:10.1136/bmj.325.7354.11 · Cited by 165
Oxidative stress, innate immunity, and age-related macular degeneration
X. Shaw, P., 1 Department of Ophthalmology and Shiley Eye Institute, U. O. C. S. D., Stiles, T., Douglas, C., Ho, D., Fan, W., Du, H., & Xiao, X. (2016) · AIMS Molecular Science · doi:10.3934/molsci.2016.2.196 · Cited by 165
Berg, K., Hadzalic, E., Gjertsen, I., Forsaa, V., Berger, L. H., Kinge, B., Henschien, H., Fossen, K., Markovic, S., Pedersen, T. R., et al. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2015.09.018 · Cited by 162
(2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.07.021 · Cited by 160
Racial/Ethnic Differences in Age-related Maculopathy
Klein, R., Rowland, M. L., & Harris, M. I. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31012-3 · Cited by 156
Anti‐Inflammatory Properties of Low and High Doxycycline Doses: An In Vitro Study
Caprio, R. D., Lembo, S., Costanzo, L. D., Balato, A., & Monfrecola, G. (2015) · Mediators of Inflammation · doi:10.1155/2015/329418 · Cited by 156
VITAMIN D STATUS AND EARLY AGE-RELATED MACULAR DEGENERATION IN POSTMENOPAUSAL WOMEN
Abraham, A., & Grigorian, A. P. (2011) · Evidence-Based Ophthalmology · doi:10.1001/archophthalmol.2011.48 · Cited by 143
Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
Stewart, M. W. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300654 · Cited by 142
Aflibercept for Age-Related Macular Degeneration: A Game-Changer or Quiet Addition?
Browning, D. J., Kaiser, P. K., Rosenfeld, P. J., & Stewart, M. W. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.04.020 · Cited by 140
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
VANDER, J. F. (2012) · Yearbook of Ophthalmology · doi:10.1016/j.yoph.2011.12.002 · Cited by 138
Wong, W. T., Kam, W., Cunningham, D., Harrington, M. W., Hammel, K., MEYERLE, C. B., Cukras, C. A., Chew, E. Y., Sadda, S. R., & Ferris, F. L. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5637 · Cited by 135
Abdominal Obesity and Age-related Macular Degeneration
Adams, M. K. M., Simpson, J. A., Aung, K. Z., Makeyeva, G. A., Giles, G. G., English, D. R., Hopper, J. L., Guymer, R. H., Baird, P. N., & Robman, L. D. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr005 · Cited by 135
Yu, J., Ba, J., Peng, R., Xu, D., Li, Y., Shi, H. M., & Wang, Q. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s86269 · Cited by 126
Smailhodzic, D., Muether, P. S., Chen, J. L., Kwestro, A., Zhang, A. Y., Omar, A., van de Ven, J. P. H., KEUNEN, J. E. E., Kirchhof, B., Hoyng, C. B., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.05.040 · Cited by 123
Pathologic features of senile macular degeneration.
Green, W. R., McDonnell, P. J., & Yeo, J. H. (1985) · PubMed · Cited by 121
Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight
Khan, J. C. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.073825 · Cited by 121
Nutritional supplements for age-related macular degeneration
Krishnadev, N., Meleth, A. D., & Chew, E. Y. (2010) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32833866ee · Cited by 118
Rayess, N., Houston, S. K. S., Gupta, O. P., Ho, A. C., & Regillo, C. D. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.09.011 · Cited by 117
Jackson, G. R., Scott, I. U., Kim, I. K., Quillen, D. A., Iannaccone, A., & Edwards, J. G. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13745 · Cited by 115
NLRP3 Inflammasome: Activation and Regulation in Age‐Related Macular Degeneration
Gao, J., Liu, R. T., Cao, S., Cui, J. Z., Wang, A., To, E. C., & Matsubara, J. A. (2015) · Mediators of Inflammation · doi:10.1155/2015/690243 · Cited by 114
Homocysteine, folate, vitamin B-12, and 10-y incidence of age-related macular degeneration
Gopinath, B., Flood, V. M., Rochtchina, E., Wang, J. J., & Mitchell, P. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.057091 · Cited by 114
Zhou, Q., Daniel, E., Maguire, M. G., Grunwald, J. E., Martin, E. R., Martín, D., & Ying, G. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.02.043 · Cited by 114
Chong, E. W.-T., Kreis, A. J., Wong, T. Y., Simpson, J. A., & Guymer, R. H. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.12.005 · Cited by 112
Campochiaro, P. A., Channa, R., Berger, B. B., Heier, J. S., Brown, D. M., Fiedler, U., Hepp, J., & Stumpp, M. T. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.09.032 · Cited by 112
Parekh, N., Voland, R. P., Moeller, S. M., Blodi, B. A., Ritenbaugh, C., Chappell, R. J., Wallace, R. B., & Mares, J. A. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.130 · Cited by 111
Engelbert, M., Zweifel, S. A., & Freund, K. B. (2010) · Retina · doi:10.1097/iae.0b013e3181d50cbf · Cited by 108
Chakravarthy, U., Harding, S. P., Rogers, C. A., Downes, S. M., Lotery, A. J., Dakin, H., Culliford, L. A., Scott, L. J., Nash, R. L., Taylor, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19780 · Cited by 107
COSCAS, G. J., Lupidi, M., Coscas, F., Français, C., Cagini, C., & Souied, E. H. (2015) · Ophthalmic Research · doi:10.1159/000433547 · Cited by 105
Influence of Treatment Parameters on Selectivity of Verteporfin Therapy
Michels, S., Hansmann, F., Geitzenauer, W., & Schmidt-Erfurth, U. M. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0354 · Cited by 105
Wong, W. T., Dresner, S., Forooghian, F., Glaser, T. S., Doss, L. E., Zhou, M., Cunningham, D., Shimel, K. H., Harrington, M. W., Hammel, K., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11650 · Cited by 103
The Amsler chart: absence of evidence is not evidence of absence
Crossland, M. D., & Rubin, G. S. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.095315 · Cited by 101
Nunes, R. P., Gregori, G., Yehoshua, Z., Stetson, P. F., Feuer, W. J., Moshfeghi, A. A., & Rosenfeld, P. J. (2013) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20130715-06 · Cited by 101
Chou, R., Dana, T., Bougatsos, C., Grusing, S., & Blazina, I. (2016) · JAMA · doi:10.1001/jama.2016.0783 · Cited by 101
SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR
Kubota, R., Boman, N. L., David, R., Mallikaarjun, S., Patil, S., & Birch, D. G. (2011) · Retina · doi:10.1097/iae.0b013e318217369e · Cited by 100
Guidance for the treatment of neovascular age-related macular degeneration
Schmidt-Erfurth, U. M., Richard, G. W., Augustin, A. J., Aylward, G. W., Bandello, F. M., Corcóstegui, B., Cunha-Vaz, J. G., Gaudric, A., LEYS, A. M., & Schlingemann, R. O. (2007) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.2007.00979.x · Cited by 96
(1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090160065024 · Cited by 95
MacLaren, R. E., Bird, A. C., Sathia, P. J., & Aylward, G. W. (2005) · Ophthalmology · doi:10.1016/j.ophtha.2005.06.029 · Cited by 94
Cipriani, V., Leung, H. T., Plagnol, V., Bunce, C., Khan, J. C., Shahid, H., Moore, A. T., Harding, S. P., Bishop, P. N., Hayward, C., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds225 · Cited by 93
Souied, E. H., Devin, F., Mauget‐Faÿsse, M., Kolář, P., Wolf-Schnurrbusch, U. E. K., Framme, C., Gaucher, D., Querques, G., Stumpp, M. T., & Wolf, S. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.05.037 · Cited by 91
Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia
Hajar, S., Hazmi, A. A., Wasli, M. A., Mousa, A., & Rabiu, M. (2015) · Saudi Medical Journal · doi:10.15537/smj.2015.4.10371 · Cited by 91
Age-Related Maculopathy in a Randomized Trial of Low-Dose Aspirin Among US Physicians
Christen, W. G. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1143 · Cited by 88
Cytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularization
Yanai, R., Mulki, L., Hasegawa, E., Takeuchi, K., Sweigard, H., Suzuki, J., Gaissert, P., Vavvas, D. G., Sonoda, K., Rothe, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401191111 · Cited by 86
Risk Assessment Model for Development of Advanced Age-Related Macular Degeneration
Klein, M. L., Francis, P. J., Ferris, F. L., Hamon, S., & Clemons, T. E. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2011.216 · Cited by 85
Stereotactic Radiotherapy for Neovascular Age-related Macular Degeneration
Jackson, T. L., Chakravarthy, U., Kaiser, P. K., Slakter, J. S., Jan, E., Bandello, F. M., O’Shaughnessy, D., Gertner, M. E., Danielson, L., & Moshfeghi, D. M. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.02.016 · Cited by 84
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2011) · BMC Ophthalmology · doi:10.1186/1471-2415-11-22 · Cited by 82
A Simplified Severity Scale for Age-Related Macular Degeneration: AREDS Report No 18
VANDER, J. F. (2006) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)70302-2 · Cited by 81
Kaiser, P. K. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.12.057 · Cited by 80
Schaumberg, D. A. (2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.3.300 · Cited by 79
Menopausal and Reproductive Factors and Risk of Age-Related Macular Degeneration
Feskanich, D., Cho, E., Schaumberg, D. A., Colditz, G. A., & Hankinson, S. E. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.4.519 · Cited by 78
Shienbaum, G., Gupta, O. P., Fecarotta, C., Patel, A. H., Kaiser, R. S., & Regillo, C. D. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.011 · Cited by 77 · cited 1×
“151 The observe-and-plan regimen is based on an initial three loading doses, followed by a monthly observation; once signs of recurrence appeared on SD-OCT, the ideal treatment interval is considered to be 2 weeks shorter than the elapsed interval.”
Mantel, I., Niderprim, S.-A., Gianniou, C., Deli, A., & Ambresin, A. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2013-304556 · Cited by 77
Moriarty-Craige, S. E., Adkison, J., Lynn, M., Gensler, G. R., Bressler, S. B., Jones, D. P., & Sternberg, P. (2005) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2005.06.043 · Cited by 76
(2000) · Time to knit · doi:10.1016/j.yoph.2014.02.025 · Cited by 76
Long-term Use of Aspirin and Age-Related Macular Degeneration
Klein, R., Howard, K. P., Gangnon, R. E., Dreyer, J. O., Lee, K. E., & Klein, R. (2012) · JAMA · doi:10.1001/jama.2012.65406 · Cited by 72
Risk factors for agerelated macular degeneration: Pooled findings from three continents
Smith, W., Assink, J. (., Klein, R., Mitchell, P., Klaver, C., Klein, B., Albert Hofman, D., Jensen, S., Wang, J., & Jong, P. D. (2001) · KNAW research portal (Royal Academy of Art and Sciences (KNAW)) · Cited by 70
Petrou, P. A., Cunningham, D., Shimel, K. H., Harrington, M. W., Hammel, K., Cukras, C. A., Ferris, F. L., Chew, E. Y., & Wong, W. T. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15877 · Cited by 69
Long-Term Blood Pressure and Age-Related Macular Degeneration: The ALIENOR Study
Cougnard‐Grégoire, A., Delyfer, M., Korobelnik, J., Rougier, M., Malet, F., Goff, M. L., Dartigues, J., Colin, J., Barberger‐Gateau, P., & Delcourt, C. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10192 · Cited by 66
Costa, R. A., Jorge, R., Calucci, D., Melo, L. A. S., Cardillo, J. A., & Scott, I. U. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-007-0557-x · Cited by 64
Aspirin Use and Risk of Age-Related Macular Degeneration: A Meta-Analysis
Zhu, W. J., Wu, Y., Xu, D., Li, Y., Ba, J., Zhang, X., Wang, F., & Yu, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058821 · Cited by 63
USE OF FUNDUS AUTOFLUORESCENCE IMAGES TO PREDICT GEOGRAPHIC ATROPHY PROGRESSION
Bearelly, S., Khanifar, A. A., Lederer, D. E., Lee, J. J., Ghodasra, J. H., Stinnett, S. S., & Cousins, S. W. (2010) · Retina · doi:10.1097/iae.0b013e3181e0958b · Cited by 58
Hyperopia and Neovascularization in Age-related Macular Degeneration
Sandberg, M. A., Tolentino, M. J., Miller, S., Berson, E. L., & Gaudio, A. R. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31546-0 · Cited by 57
Elshout, M., van der Reis, M. I., Webers, C. A. B., & Schouten, J. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2641-3 · Cited by 56
Barondes, M. J., Pauleikhoff, D., Chisholm, I. H., Minassian, D. C., & Bird, A. C. (1990) · British Journal of Ophthalmology · doi:10.1136/bjo.74.3.180 · Cited by 55
Landa, G., Butovsky, O., Shoshani, J., Schwartz, M., & Pollack, A. (2008) · Current Eye Research · doi:10.1080/02713680802484637 · Cited by 54
Mantel, I. (2015) · Translational Vision Science & Technology · doi:10.1167/tvst.4.3.6 · Cited by 51
Could Blue Light–Blocking Lenses Decrease the Risk of Age-Related Macular Degeneration?
Glazer-Hockstein, C., & Dunaief, J. L. (2006) · Retina · doi:10.1097/00006982-200601000-00001 · Cited by 50
Age-Related Macular Degeneration: A Complementopathy?
Kijlstra, A., & Berendschot, T. T. J. M. (2015) · Ophthalmic Research · doi:10.1159/000432401 · Cited by 47
Batıoğlu, F., Oğuz, Y. G., Demirel, S., & Özmert, E. (2014) · Ophthalmic Research · doi:10.1159/000361077 · Cited by 47
Park, D. H., Sun, H. J., & Lee, S. J. (2016) · International Ophthalmology · doi:10.1007/s10792-016-0391-4 · Cited by 47
Gianniou, C., Dirani, A., Ferrini, W., Marchionno, L., Decugis, D., Deli, A., Ambresin, A., & Mantel, I. (2014) · Eye · doi:10.1038/eye.2014.258 · Cited by 44
VANDER, J. F. (2008) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(08)79098-1 · Cited by 41
VANDER, J. F. (2011) · Yearbook of Ophthalmology · doi:10.1016/j.yoph.2010.12.010 · Cited by 35
Chen, F. K., Patel, P. J., Uppal, G., Tufail, A., Coffey, P. J., & da Cruz, L. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.172593 · Cited by 33
Maller, J., George, S., Purcell, S., Fagerness, J. A., Altshuler, D., Daly, M. J., & Seddon, J. M. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.012 · Cited by 32
Neffendorf, J. E., Desai, R., Wang, Y., Kelly, J., Murphy, C., Reeves, B. C., Chakravarthy, U., Wordsworth, S., Lewis, C., Peacock, J. L., et al. (2016) · Trials · doi:10.1186/s13063-016-1676-7 · Cited by 31
Au, A. C., Parikh, V. S., Singh, R. P., Ehlers, J. P., Yuan, A., Rachitskaya, A. V., Sears, J. E., Srivastava, S. K., Kaiser, P. K., SCHACHAT, A. P., et al. (2016) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2016-309434 · Cited by 30
Kodjikian, L., Souied, E. H., Mimoun, G., Decullier, É., Huot, L., & Aulagner, G. (2013) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2013.4461.x · Cited by 26
Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration
Giansanti, F., Eandi, C. M., & Virgili, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006931.pub2 · Cited by 26
van Romunde, S. H. M., Polito, A., Bertazzi, L., Guerriero, M., & Pertile, G. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.03.012 · Cited by 25
Piermarocchi, S., Sartore, M., Giudice, G. L., Maritan, V., Midena, E., & Segato, T. (2008) · Archives of Ophthalmology · doi:10.1001/archopht.126.10.1367 · Cited by 25
Quiñones, S. M., Ballús, M. M. I., Sararols, L., & Mora, J. (2003) · Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears · Cited by 23
Söderberg, A.-C., Algvere, P. V., Hengstler, J. C., Söderberg, P., Seregard, S., & Kvanta, A. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2011-300721 · Cited by 21
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Milman, T. (2012) · Yearbook of Ophthalmology · doi:10.1016/j.yoph.2011.08.010 · Cited by 21
Vottonen, P., & Kankaanpää, E. (2016) · Acta Ophthalmologica · doi:10.1111/aos.13185 · Cited by 20
Ranjbar, M., Kurz, M., Holzhey, A., Melchert, C., Rades, D., & Grisanti, S. (2016) · Medicine · doi:10.1097/md.0000000000005729 · Cited by 20
Kim, B. J., Ying, G., Huang, J., Levy, N. E., & Maguire, M. G. (2014) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2014.04.004 · Cited by 19
Medina, F. M. C., da Motta, A. A. L., Takahashi, W. Y., Carricondo, P. C., Motta, M. M. D. S., de Melo, M. B., & de Vasconcellos, J. P. C. (2015) · Ophthalmic Research · doi:10.1159/000439172 · Cited by 19
Risk factors for age-related maculopathy: the Visual Impairment Project
McCarty, C. A., Mukesh, B. N., Fu, C. L. H., MITCHELL, P., Wang, J. J., & Taylor, H. R. (2001) · Minerva Access (University of Melbourne) · Cited by 18
Shaikh, A. H., Toussaint, B. W., Miller, D. M., Petersen, M. R., Foster, R. E., Riemann, C. D., Hutchins, R. K., & Sisk, R. A. (2015) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20150101-10 · Cited by 17
Tsai, J. C. (2013) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2013.02.003 · Cited by 15
Risk Factors for Age-Related Maculopathy: The Visual Impairment Project
McCarty, C. A. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.10.1455 · Cited by 12
QUANTIFICATION OF FLUORESCEIN-STAINED DRUSEN ASSOCIATED WITH AGE-RELATED MACULAR DEGENERATION
Friedman, D. A., Parker, J. S., Kimble, J. A., Delori, F. C., McGwin, G., & Curcio, C. A. (2011) · Retina · doi:10.1097/iae.0b013e318219e5e9 · Cited by 11
Gaynes, B. I., & Fiscella, R. G. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.4.345 · Cited by 11
Johnson, P. T., Betts, K. E., Radeke, M. J., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.01.013 · Cited by 9
Haller, J. A. (2007) · Evidence-Based Ophthalmology · doi:10.1097/ieb.0b013e31809fddb0 · Cited by 4
Cited by
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Luan, Y.-Y., & Yao, Y.-M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01302 · Cited by 396
The Role of Inflammation in Age-Related Macular Degeneration
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49890 · Cited by 311
Lipid nanoparticles for the posterior eye segment
Bonilla, L., Espina, M., Severino, P., Cano, A., Ettcheto, M., Camins, A., García, M. L., Souto, E. B., & Sánchez-López, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010090 · Cited by 76
Age-Related Retinal Changes in Wild-Type C57BL/6J Mice Between 2 and 32 Months
Ferdous, S., Liao, K. L., Gefke, I. D., Summers, V. R., Wu, W., Donaldson, K. J., Kim, Y.-K., Sellers, J. T., Dixon, J. A., Shelton, D. A., et al. (2021) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.62.7.9 · Cited by 70
Metadata
- Authors
- Al-Zamil, W., & Yassin, S.
- Venue
- Clinical Interventions in Aging
- Publisher
- Informa UK Limited
- Published
- 2017-08
- Volume
- Volume 12
- Pages
- 1313-1330
- ISSN
- 1176-9092 (ISSN-L)
- 1178-1998
- OpenAlex
- W2747725012
- Cited by
- 406
- References
- 190
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.